BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,868 | +72058.0% | 33,940 | +89.5% | 0.01% | -28.6% |
| Q2 2023 | $119 | -83.2% | 17,908 | -52.7% | 0.01% | -83.7% |
| Q1 2023 | $707 | -16.0% | 37,887 | -3.3% | 0.04% | -17.3% |
| Q4 2022 | $842 | -99.8% | 39,185 | +14.5% | 0.05% | +92.6% |
| Q3 2022 | $405,000 | -11.6% | 34,231 | -1.4% | 0.03% | -3.6% |
| Q2 2022 | $458,000 | -37.8% | 34,705 | -1.5% | 0.03% | -28.2% |
| Q1 2022 | $736,000 | +5.0% | 35,221 | +2.1% | 0.04% | +14.7% |
| Q4 2021 | $701,000 | -28.6% | 34,502 | +6.7% | 0.03% | -34.6% |
| Q3 2021 | $982,000 | +58.9% | 32,344 | +52.1% | 0.05% | +57.6% |
| Q2 2021 | $618,000 | – | 21,270 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |